Decline in lung function and mortality: The Busselton health study

Journal of Epidemiology and Community Health

Volumn 53, Issue 4, 1999, Pages 230-234

  Ryan, Gerard ^a   Knuiman, Matthew W ^b   Divitini, Mark L ^b   James, Alan ^a   Musk, A W ^a   Bartholomew, Helen C ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEATH CERTIFICATE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORMAL HUMAN; PUBLIC HEALTH; SMOKING; STATISTICS;

EID: 0033016502     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.4.230     Document Type: Article

References (33)

1. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health 1970;21:418-24.
2. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham Study. Am Heart J 1983;105:311-15.
3. Beatv TH, Cohen BH, Newill CA, et al. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982;116:102-13.
4. Cullen K, Stenhouse NS, Wearne KL, et al. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13 year study. J Chron Dis 1983;36:371-7.
5. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983;128:491-500.
6. Krzvanowski M, Wysocki M. The relation of thirteen year mortality to ventilatory impairment and other respiratory symptoms: The Cracow Study. Int J Epidemiol 1986;15:56-64.
7. Vollmer WM, McCamant LE, Johnson LR, et al. Respiratory symptoms, lung function and mortality in a screening center cohort. Am J Epidemiol 1989;129:1157-69.
8. Ebi-Kryston KL, Hawthorne VM, Rose G, et al. Breathlessness chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol 1989;18:84-8.
9. Ebi-Kryston KL. Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Community Health 1989;43:168-72.
10. Marcus EB, Curb JD, MacLean CJ, et al. Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989;129:97-104.
11. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990:45:579-86.
12. Lange P, Nyboe J, Appleyard M, et al. Spirometric findings and mortality in never smokers. J Clin Epidemiol 1990,43: 867-73.
13. 1) to lung cancer mortality in the Multiple Risk Factor Intervention Trail (MRFIT). Am J Epidemiol 1990;132:265-14.
14. Strachan DP. Ventilatory function as a predictor of fatal stroke. BMJ 1991;302:84-7.
15. Van den Eeden SK, Friedman GD. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology 1992;3:253-7.
16. Bang KM, Gergen PJ, Kramer R, et al. The effect of pulmonary impairment on all cause mortality in a national cohort. Chest 1993;103:536-40.
17. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women, findings from the Renfrew and Paisley prospective study. BMJ 1996;313:711-15.
18. 1 by age and smoking status: facts, figures and fallacies. Thorax 1997;52:820-7.
19. Rodriguez BL, Masaki K, Burchfiel C, et al. Pulmonary function decline and 17-year total mortality: The Honolulu Heart Program. Am J Epidemiol 1994;140:398-408.
20. 1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med 1995;151:390-8.
21. Xu X, Dockery DW, Ware JH, et al. Decline of pulmonary function as a predictor of mortality in adults. Am Rev Respir Dis 1992;145:A198.
22. Cullen KJ. Mass health examinations in the Busselton population, 1966 to 1970. Med J Aust 1972;2:714-18.
23. Webster IW. Busselton, a community study in cardiovascular disease. Aust. NZ J Med 1974;4:412-14.
24. Knuiman MW, Cullen KJ, Bulsara MK, et al. Mortality trends, 1965 to 1989, in Busselton, the site of repeated health surveys and interventions. Aust J Public Health 1994;18:129-35.
25. Knuiman MW, Jamrozik K, Welborn TA, et al. Age and secular trends in risk factors for cardiovascular disease in Busselton. Aust J Public Health 1995;19:375-82.
26. Welborn TA, Cumptson GN, Cullen KJ, et al. The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol 1969;89: 521-36.
27. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
28. SAS/STAT Software. Changes and enhancements through release 6. 12. North Carolina, USA: SAS Institute Inc 1997.
29. Peat JK, Woolcock AJ, Cullen KJ. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70: 171-9
30. Musk AW, Ryan GF, Perera DM, et al. Mortality from asthma in Western Australia. Med J Aust 1987;147:423-7
31. Schoulen JP, Taper IB. Interpretation of longitudinal studies. Am J Respir Crit Care Med 1996;154:5278-84.
32. Ware JH, Dockery DW, Louis TA, et al. Longitudinal and cross sectional estimates of pulmonary function decline in never smoking adults. Am J Epidemiol 1990;132:685-700.
33. American Thoracic Society. Standardization of spirometry. Am Rev Respir Dis 1979;119:831-8.